Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 14;24(1):83.
doi: 10.1186/s12890-024-02890-5.

Understanding changes in pulmonary function and functional status in breast cancer patients after systemic chemotherapy and radiotherapy: a prospective study

Alper Tuğral  1 , Zeynep Arıbaş  2 , Murat Akyol  3 , Yeşim Bakar  4
Affiliations

Understanding changes in pulmonary function and functional status in breast cancer patients after systemic chemotherapy and radiotherapy: a prospective study

Alper Tuğral et al. BMC Pulm Med. .

Abstract

Background: Respiratory complications in breast cancer (BC) patients after chemotherapy (CT) and radiotherapy (RT) have been well acquainted and these complications should be investigated to prevent secondary problems and/or improve BC patients' clinical outcomes. Therefore, this study aimed to assess the potential acute effect of systemic chemotherapy and radiotherapy on respiratory function and functional status of patients with breast cancer.

Methods: A total of 25 BC patients who were candidates for systemic chemotherapy and radiotherapy were recruited after oncological examination and included in this study. Respiratory function and functional status were assessed with the Pulmonary Function Test (PFT) and the Six-Minute Walk Test (6MWT), respectively. Patients were assessed before CT (c0), after CT (c1), and after RT (r1).

Results: 25 BC patients were assessed in c0 and c1 while only 15 out of 25 patients (60%) were assessed in r1. The actual values of Forced vital capacity (FVC) (t = 2.338, p =.028), Forced expiratory volume in 1s (FEV1 (t = 2.708, p =.012), and the forced expiratory flow of between 25% and 75% of vital capacity (FEF25-75%) (t = 2.200, p =.038) were found significantly different after systemic CT. Inspiratory (MIP) and expiratory (MEP) muscle strength also did not show a significant change from c0 to c1. A significant effect of the type of surgery was found (Wilks' lambda, F [1, 19] = 6.561, p =.019, ηp2 = 0.25) between c0 and c1 in actual FVC value. The main effect of time was found significant in FVC (F [2, 28] = 4.840, p =.016, ηp2 = 0.25) from c0 to r1. Pairwise comparisons with Bonferroni correction showed that there was a significant difference between c0 and r1 (p =.037).

Discussion: The present study showed decreased FVC and FEV1 actual values and percent predicted rates from baseline to the completion of treatment. Since the interactional effect of the type of surgery was significant, we suggest that clinical and demographic factors such as age should be considered when interpreting the early changes in PFT. In addition, the significant linear trend of decreasing in some specific outcomes in respiratory function also highlighted the need for continuous monitoring of potential respiratory problems in patients with BC from baseline to the completion of chemotherapy and radiotherapy.

Keywords: Breast cancer; Chemotherapy; Pulmonary function test; Radiotherapy; Six-minute walk test.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no conflicts of interest.

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of the study process
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Society AC. How common is breast cancer? Breast Cancer Stat, 20190. 2020.
    1. Wang L, Li J, Wang T, Xie Y, Fan Z, He Y, et al. Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy. Zhonghua Wai Ke Za Zhi. 2021;59(2):127–33. - PubMed
    1. Stan D, Loprinzi CL, Ruddy KJ. Breast cancer survivorship issues. Hematol Oncol Clin North Am. 2013;27(4):805–27. doi: 10.1016/j.hoc.2013.05.005. - DOI - PMC - PubMed
    1. Shannon VR, Price KJ. Pulmonary complications of cancer therapy. Anesthesiol Clin. 1998;16(3):563–86. doi: 10.1016/S0889-8537(05)70043-2. - DOI
    1. Ding L, Wang L, Yin J, Fan Z, He Z. Effects of neoadjuvant chemotherapy on respiratory function in patients with breast cancer. Chin J Cancer Res. 2020;32(1):36–42. doi: 10.21147/j.issn.1000-9604.2020.01.05. - DOI - PMC - PubMed